Normal-Weight Type 2 Diabetes Patients Have Higher Mortality Risk

Share this content:
Normal-Weight Type 2 Diabetes Patients Have Higher Mortality Risk
Normal-Weight Type 2 Diabetes Patients Have Higher Mortality Risk

(HealthDay News) — In older adults with type 2 diabetes, muscle size may mediate the association between BMI and mortality, according to research published in Diabetes Care.

Rachel A. Murphy, MD, of the National Institute on Aging in Bethesda, Maryland, and colleagues analyzed data from the AGES-Reykjavik cohort of participants, aged 66 to 96 years, with type 2 diabetes. The researchers sought to investigate whether adipose tissue, muscle size and physical function, which vary by weight, mediate associations between BMI and mortality. 

Participants were normal weight (18.5 to 24.9, 117 participants), overweight (25.0 to 29.9, 293 participants [referent group]) or obese (≥30.0, 227 participants).

The researchers found that, compared with overweight participants, there was no mortality risk for obese participants and an increased risk for mortality for normal-weight participants (hazard ratio [HR]=1.72; 95% CI, 1.12-2.64). 

After adjustment for adipose tissue and knee extensor strength, these associations persisted. Mortality risk for normal-weight participants was attenuated after adjustment for thigh muscle (HR=1.36; 95% CI, 0.87-2.11) and gait speed (HR=1.44; 95% CI, 0.91-2.27). 

Further analysis confirmed that thigh muscle size mediated 46% of the relationship between normal weight and mortality risk.

"In conclusion, the results illustrate the importance of identifying type 2 diabetes among normal-weight individuals and suggest that muscle size may help to explain relationships between BMI and mortality in type 2 diabetes," the researchers wrote.

Reference

  1. Murphy RA et al. Diabetes Care. 2014;doi:10.2337/dc14-0293.
You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters

CME Focus